Report
Nikolaas Faes

Canopy Growth: Canada legalises recreational cannabis

Canopy Growth: (BUY, Fair Value C$51 (+20%))
Canada legalises recreational cannabis
Yesterday evening, the Canadian Senate voted to fully legalise cannabis (52-29) paving the way for recreational cannabis to be legally bought and sold within the next two or three months.
Underlying
Canopy Growth Corporation

Canopy Growth is a licensed producer of medical marijuana in Canada. The principal activities of Co. are the production and sale of marijuana out of its facility in Smiths Falls, Ontario as regulated by the "Marijuana for Medical Purposes Regulations".

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Nikolaas Faes

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch